S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

CPRX Catalyst Pharmaceuticals Inc

21.21

0.05 (0.24%)

19 Oct 2024 - Closed

Delayed by 15 minutes

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Catalyst Pharmaceuticals (NASDAQ:CPRX)
Historical Stock Chart
From Sep 2024 to Oct 2024

Click Here for more Catalyst Pharmaceuticals Charts.

Catalyst Pharmaceuticals (NASDAQ:CPRX)
Historical Stock Chart
From Oct 2023 to Oct 2024

Click Here for more Catalyst Pharmaceuticals Charts.

Catalyst Pharmaceuticals Inc News

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Saturday 19 October 2024 (2 days ago) • Edgar (US Regulatory)

Catalyst Pharmaceuticals Donates $100,000 to the American Red Cross Hurricane Helene Relief Efforts
Tuesday 8 October 2024 (2 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 26 September 2024 (4 weeks ago) • Edgar (US Regulatory)

Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Received Approval to Commercialize FIRDAPSE® in Japan
Tuesday 24 September 2024 (4 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Friday 23 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Wednesday 21 August 2024 (2 months ago) • Edgar (US Regulatory)

Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences
Tuesday 20 August 2024 (2 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 14 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Saturday 10 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 8 August 2024 (2 months ago) • Edgar (US Regulatory)

Catalyst Pharmaceuticals Reports Strong Second Quarter 2024 Financial Results and Provides Corporate Update
Thursday 8 August 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Saturday 27 July 2024 (3 months ago) • Edgar (US Regulatory)

More Catalyst Pharmaceuticals Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions